Atlassian (NASDAQ:TEAM) Sets New 12-Month Low Following Insider Selling

Shares of Atlassian Corporation PLC (NASDAQ:TEAM) reached a new 52-week low on Thursday following insider selling activity. The stock traded as low as $115.01 and last traded at $118.5370, with a volume of 4526947 shares trading hands. The stock had previously closed at $134.76.

Specifically, CEO Michael Cannon-Brookes sold 7,665 shares of the company’s stock in a transaction dated Wednesday, January 28th. The stock was sold at an average price of $135.44, for a total transaction of $1,038,147.60. Following the sale, the chief executive officer owned 321,930 shares in the company, valued at approximately $43,602,199.20. This represents a 2.33% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Scott Farquhar sold 7,665 shares of the firm’s stock in a transaction that occurred on Wednesday, January 28th. The shares were sold at an average price of $135.44, for a total value of $1,038,147.60. Following the completion of the transaction, the director owned 321,930 shares of the company’s stock, valued at approximately $43,602,199.20. This represents a 2.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In other news, Director Scott Farquhar sold 7,665 shares of the company’s stock in a transaction that occurred on Monday, January 26th. The stock was sold at an average price of $136.93, for a total transaction of $1,049,568.45. Following the sale, the director owned 337,260 shares in the company, valued at $46,181,011.80. This represents a 2.22% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.

Analyst Ratings Changes

Several equities analysts recently weighed in on TEAM shares. The Goldman Sachs Group reissued a “buy” rating and issued a $260.00 target price on shares of Atlassian in a research note on Friday, October 31st. Macquarie decreased their price objective on shares of Atlassian from $250.00 to $240.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Sanford C. Bernstein boosted their price objective on shares of Atlassian from $290.00 to $304.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 18th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $240.00 target price on shares of Atlassian in a research note on Friday, October 31st. Finally, UBS Group set a $145.00 price target on Atlassian in a research report on Tuesday. Twenty research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Atlassian has an average rating of “Moderate Buy” and a consensus price target of $227.60.

Key Headlines Impacting Atlassian

Here are the key news stories impacting Atlassian this week:

• Positive Sentiment: Marketing / brand exposure — Atlassian’s Williams F1 team added Wilkinson Sword as an official partner, which can help enterprise brand awareness and demand generation over time. Read More.
• Neutral Sentiment: AI competitive landscape — Coverage highlights Anthropic’s Cowork as a potential disruptor to collaboration/workflow tools; important context for long‑term competitive risk but speculative for immediate fundamentals. Read More.
• Neutral Sentiment: Context pieces explain drivers behind today’s selloff (useful background but not new company financials). Read More.
• Negative Sentiment: Insider selling — CEO Michael Cannon‑Brookes and director Scott Farquhar executed multiple same‑period share sales (several blocks of ~7,665 shares), signaling near‑term negative sentiment and adding selling supply. Read More.
• Negative Sentiment: Legal risk — Pomerantz LLP launched an investor investigation into Atlassian, which can prolong downward pressure until claims are clarified or dismissed. Read More.
• Negative Sentiment: Analyst / sell‑side pressure — Recent analyst target reductions and negative notes (coverage cited) reduce near‑term upside expectations and can accelerate selling. Read More.
• Negative Sentiment: Bearish momentum — Stock hit a new 52‑week low and reports cite higher short interest, which can amplify declines via momentum and short‑term trading flows. Read More.

Atlassian Stock Performance

The company has a fifty day moving average of $148.99 and a two-hundred day moving average of $161.52. The firm has a market capitalization of $31.09 billion, a price-to-earnings ratio of -166.45, a PEG ratio of 18.64 and a beta of 0.88. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.26 and a current ratio of 1.26.

Atlassian (NASDAQ:TEAM) last posted its quarterly earnings data on Thursday, October 30th. The technology company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.21. The firm had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.40 billion. Atlassian had a negative return on equity of 7.11% and a negative net margin of 3.38%.The company’s quarterly revenue was up 20.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.77 EPS. As a group, equities research analysts predict that Atlassian Corporation PLC will post -0.34 earnings per share for the current fiscal year.

Institutional Trading of Atlassian

Several hedge funds and other institutional investors have recently bought and sold shares of the business. NewEdge Advisors LLC grew its position in Atlassian by 71.6% during the first quarter. NewEdge Advisors LLC now owns 5,432 shares of the technology company’s stock worth $1,153,000 after buying an additional 2,267 shares in the last quarter. Empowered Funds LLC lifted its position in shares of Atlassian by 39.5% during the 1st quarter. Empowered Funds LLC now owns 4,689 shares of the technology company’s stock valued at $995,000 after acquiring an additional 1,328 shares during the period. Focus Partners Wealth grew its holdings in shares of Atlassian by 32.6% during the 1st quarter. Focus Partners Wealth now owns 4,122 shares of the technology company’s stock worth $875,000 after purchasing an additional 1,014 shares in the last quarter. Geneos Wealth Management Inc. increased its position in shares of Atlassian by 447.2% in the first quarter. Geneos Wealth Management Inc. now owns 197 shares of the technology company’s stock worth $42,000 after purchasing an additional 161 shares during the period. Finally, Sivia Capital Partners LLC increased its position in shares of Atlassian by 27.5% in the second quarter. Sivia Capital Partners LLC now owns 1,873 shares of the technology company’s stock worth $380,000 after purchasing an additional 404 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

Atlassian Company Profile

Atlassian Corporation Plc is a software company headquartered in Sydney, Australia, best known for developing collaboration, project management and software development tools. Founded in 2002 by Mike Cannon-Brookes and Scott Farquhar, Atlassian grew from a small engineering-focused team into a publicly traded company after its initial public offering in 2015. The company serves a global customer base that spans small teams to large enterprises across technology, financial services, government and other sectors.

Atlassian’s product portfolio centers on tools designed to help teams plan, build and support software and business processes.